QLGN icon

Qualigen Therapeutics
QLGN

Overview Fund Trends Analyst Outlook Journalist POV

10 hedge funds and large institutions have $1.36M invested in Qualigen Therapeutics in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $
Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$7.91M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$316K
2
+$186K
3
+$78.8K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$21K
5
Citadel Advisors
Citadel Advisors
Florida
+$19K

Top Sellers

1
-$753K
2
-$111K
3
-$3K
4
CIBC Private Wealth Group
CIBC Private Wealth Group
Georgia
-$3K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$521K
2
$339K
3
$186K
4
$105K
5
$68K
6
$24K
7
$21K
8
$20K
9
$20K
10
$19K
11
$19K
12
$9K
13
$3K
14
$2K
15
$2K
16
$1K
17
–
18
–
19
–
20
–